𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

✍ Scribed by Timothy Smith; Alex S. Befeler

Publisher
Springer
Year
2007
Tongue
English
Weight
140 KB
Volume
9
Category
Article
ISSN
1522-8037

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High-dose ursodeoxycholic acid for the t
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
✍ Keith D. Lindor; Kris V. Kowdley; Velimir A. C. Luketic; M. Edwyn Harrison; Timo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 319 KB πŸ‘ 1 views

Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of highdose UDCA (28-30 mg/kg/day) ve

Effect of high-dose ursodeoxycholic acid
Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis
✍ Daniel Rost; Gerda Rudolph; Petra Kloeters-Plachky; Adolf Stiehl πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 1 views

Ursodeoxycholic acid (UDCA) has beneficial effects in cholestatic liver diseases. In primary sclerosing cholangitis (PSC), there is evidence that high doses (؎20 mg/kg) of UDCA may be more effective than average doses. Biliary enrichment of UDCA at such high doses may represent the decisive factor f